Lorazepam - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for lorazepam and what is the scope of freedom to operate?

Lorazepam is the generic ingredient in six branded drugs marketed by Almatica, Amneal Pharms, Chartwell Molecular, Hikma, Lupin Ltd, Pharm Assoc, Bedford, Dr Reddys, Endo Operations, Epic Pharma Llc, Hospira, Intl Medication Sys, Rising, Watson Labs, Bedford Labs, Roxane, Bausch, Quantum Pharmics, Am Therap, Anda Repository, Ani Pharms, Aurolife Pharma Llc, Chartwell Rx, Halsey, Leading, Mutual Pharm, Oxford Pharms, Par Pharm, Sandoz, Sun Pharm Inds Ltd, Superpharm, Usl Pharma, and Warner Chilcott, and is included in seventy NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Lorazepam has thirty-five patent family members in thirty countries.

There are eleven drug master file entries for lorazepam. Thirty-seven suppliers are listed for this compound.

Summary for lorazepam

International Patents:	35
US Patents:	1
Tradenames:	6
Applicants:	33
NDAs:	70
Drug Master File Entries:	11
Finished Product Suppliers / Packagers:	37
Raw Ingredient (Bulk) Api Vendors:	37
Clinical Trials:	198
Patent Applications:	6,953
Drug Prices:	Drug price trends for lorazepam
Drug Sales Revenues:	Drug sales revenues for lorazepam
What excipients (inactive ingredients) are in lorazepam?	lorazepam excipients list
DailyMed Link:	lorazepam at DailyMed

See drug prices for lorazepam

See drug sales revenues for lorazepam

Recent Clinical Trials for lorazepam

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Laureate Institute for Brain Research, Inc.	Phase 4
California Institute of Technology	Phase 4
BioXcel Therapeutics Inc	Phase 4

See all lorazepam clinical trials

Pharmacology for lorazepam

Drug Class	Benzodiazepine

Medical Subject Heading (MeSH) Categories for lorazepam

Anti-Anxiety Agents
Anticonvulsants
Antiemetics
GABA Modulators
Hypnotics and Sedatives

Anatomical Therapeutic Chemical (ATC) Classes for lorazepam

N05BA	Benzodiazepine derivatives
N05B	ANXIOLYTICS
N05	PSYCHOLEPTICS
N	Nervous system

US Patents and Regulatory Information for lorazepam

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hikma	LORAZEPAM INTENSOL	lorazepam	CONCENTRATE;ORAL	072755-001	Jun 28, 1991	AA	RX	No	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Mutual Pharm	LORAZEPAM	lorazepam	TABLET;ORAL	070474-001	Dec 10, 1985		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Roxane	LORAZEPAM	lorazepam	SOLUTION;ORAL	074648-001	Mar 18, 1997		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sandoz	LORAZEPAM	lorazepam	TABLET;ORAL	071141-001	Apr 21, 1987	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bedford Labs	LORAZEPAM PRESERVATIVE FREE	lorazepam	INJECTABLE;INJECTION	077074-002	Jul 13, 2005		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Amneal Pharms	LORAZEPAM	lorazepam	TABLET;ORAL	078826-002	Jun 23, 2010		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pharm Assoc	LORAZEPAM	lorazepam	CONCENTRATE;ORAL	090260-001	Jun 15, 2010	AA	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for lorazepam

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Hikma	ATIVAN	lorazepam	INJECTABLE;INJECTION	018140-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Hikma	ATIVAN	lorazepam	INJECTABLE;INJECTION	018140-002	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for lorazepam

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
China	105209018	Sustained release formulations of lorazepam	⤷ Sign Up
Canada	2897302	FORMULATIONS A LIBERATION PROLONGEE DE LORAZEPAM (SUSTAINED RELEASE FORMULATIONS OF LORAZEPAM)	⤷ Sign Up
Chile	2015001920	Formulaciones de lorazepam de liberación sostenida	⤷ Sign Up
Australia	2014205440	Sustained release formulations of lorazepam	⤷ Sign Up
Israel	239777	תכשירים רוקחיים בעלי שחרור מושהה של לוראזפאם (Sustained release formulations of lorazepam)	⤷ Sign Up
Japan	6039823		⤷ Sign Up
Russian Federation	2678324	СОСТАВЫ ЛОРАЗЕПАМА С ЗАМЕДЛЕННЫМ ВЫСВОБОЖДЕНИЕМ (FORMULATIONS OF LORAZEPAM WITH SUSTAINED RELEASE)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.